Northridge, CANCT07170917Now EnrollingIRB Ready

Hidradenitis Suppurativa Clinical Trial in Northridge, CA

Access cutting-edge hidradenitis suppurativa treatment through this clinical trial at a research site in Northridge. Study-provided care at no cost to qualified participants.

Sponsored by Sanofi

Quick Self-Assessment

See if you qualify for this Northridge location

Preparing your pre-screening questions…

Expert Care in Northridge

Access hidradenitis suppurativa specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related hidradenitis suppurativa treatment provided free

Apply for This Northridge Location

Check if you qualify for this hidradenitis suppurativa clinical trial in Northridge, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Northridge

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Northridge site if eligible
  4. 4Begin participation

About This Hidradenitis Suppurativa Study in Northridge

This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of the main study is to assess the efficacy and safety of brivekimig in a dose-ranging study of participants with moderate to severe HS. Study details include: The study duration (per participant) will be up to approximately 60 weeks for participants not transitioning into the long-term extension (LTE) study and will be up to approximately 52 weeks for participants transitioning into the LTE study. The randomized treatment duration will be up to approximately 48 weeks.

Sponsor: Sanofi

Who Can Participate

Inclusion Criteria

Participants with a diagnosis of moderate to severe hidradenitis suppurativa (HS) for at least 6 months prior to Baseline
Participants must have HS lesions present in at least 2 distinct anatomic areas (eg, left and right axilla; or left axilla and left inguinocrural fold), one of which must be Hurley Stage II or Hurley Stage III.
Participant must have had an inadequate response to a trial of an oral antibiotic for treatment of HS, exhibited recurrence after discontinuation of antibiotics, demonstrated intolerance to antibiotics, or has a contraindication to oral antibiotics for treatment of their HS as assessed by the Investigator through participant interview and review of medical history.
Participants must be either biologic-naive or biologic-experienced.
Participant must have a total abscess and inflammatory nodule (AN) count of ≥5 at the Baseline visit.
Participant must have a draining tunnel count of ≤20 at the Baseline visit.

Exclusion Criteria

Participants are excluded from the study if any of the following criteria apply:
Any other active skin disease or condition (eg, bacterial, fungal, or viral infection) that may interfere with assessment of HS
History of recurrent or recent serious infection
Known history of significant immunosuppression
History of solid organ transplant or stem cell transplant
History of splenectomy
History of moderate to severe congestive heart failure.
History of demyelinating disease (including myelitis) or neurologic symptoms suggestive of demyelinating disease
Participants with a history of malignancy or lymphoproliferative disease other than adequately treated or nonmetastatic squamous cell carcinoma of the skin that was excised and completely cured or nonmetastatic basal cell carcinoma of the skin that was excised and completely cured
History of any other condition which, in the opinion of the Investigator, would put the participant at risk by participation in the protocol
Active suicidality and therefore significant suicide risk, as judged by the Investigator
A history of an Adverse Event (AE) attributed to or related to anti-TNF therapy (examples include, but are not limited, to serum sickness or anaphylaxis) for an HS or non-HS indication that would contraindicate readministration of an anti-TNF class therapy
Sensitivity to any of the study interventions, or components thereof, or drug or other allergy that, in the opinion of the Investigator, contraindicates participation in the study
History (within last 2 years prior to Baseline visit) of prescription drug or substance abuse, including alcohol, considered significant by the Investigator The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Northridge?

Yes, this clinical trial (NCT07170917) has an active research site in Northridge, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Hidradenitis Suppurativa Treatment Options in Northridge, CA

If you're searching for hidradenitis suppurativa treatment options in Northridge, CA, this clinical trial (NCT07170917) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Northridge research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all hidradenitis suppurativa clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Northridge, CA

See all alzheimers disease clinical trials recruiting in Northridge — not just this study.

Browse Alzheimers Disease Trials in Northridge →

Browse More Trials by Condition

Alzheimers Disease TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsHidradenitis Suppurativa TrialsAll Conditions →

Ready to Join in Northridge?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Northridge, CA